<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="368">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 24, 2013</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01801488</url>
  </required_header>
  <id_info>
    <org_study_id>IRB#238810</org_study_id>
    <nct_id>NCT01801488</nct_id>
  </id_info>
  <brief_title>Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm</brief_title>
  <official_title>Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State University of New York - Upstate Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>State University of New York - Upstate Medical University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Test single nucleotide polymorphisms (SNP's) in ruptured and unruptured aneurysm tissue to
      identify a genetic difference between the two types of aneurysms; and to test SNP's in
      arteriovenous malformation tissue to identify a genetic link.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2011</start_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Risk gene expression</measure>
    <time_frame>Within one week of sample collection.</time_frame>
    <safety_issue>No</safety_issue>
    <description>The samples will be frozen after collection and then analyzed.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Arteriovenous Malformations</condition>
  <condition>Intracranial Aneurysm</condition>
  <condition>Subarachnoid Hemorrhage</condition>
  <arm_group>
    <arm_group_label>AVM Patients</arm_group_label>
    <description>Patients receiving surgical intervention for an intracranial arterial-venous malformation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ruptured Aneurysm</arm_group_label>
    <description>Patients receiving surgical intervention for a ruptured intracranial aneurysm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unruptured Aneurysm</arm_group_label>
    <description>Patients receiving surgical intervention for an unruptured intracranial aneurysm.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tissue samples of intracranial arterial-venous malformations (AVM) or aneurysm and blood
      samples.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to University Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult patients between the ages of 18 and 89 that are having open surgical
             resection of an AVM or clipping of an aneurysm will be included

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric M Deshaies, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SUNY Upstate Medical University Neurosurgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mark R Villwock, MS</last_name>
    <phone>315-464-5502</phone>
    <email>villwocm@upstate.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark R Villwock, MS</last_name>
      <phone>315-464-5502</phone>
      <email>villwocm@upstate.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 26, 2013</lastchanged_date>
  <firstreceived_date>December 12, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Arteriovenous Malformations</mesh_term>
    <mesh_term>Hemangioma</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
